← FDA Drug Approvals (Drugs@FDA)

NOURIANZ

NDA · New Drug Application · Sponsor: KYOWA KIRIN · Approved 2019-08-27

Drug application

FDA Application #

NDA022075

Application type

New Drug Application

Brand name

NOURIANZ

Generic name

ISTRADEFYLLINE

Active ingredients

ISTRADEFYLLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

KYOWA KIRIN

Manufacturer

Kyowa Kirin, Inc.

First approval

2019-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown